ESR1 Archives - Medical Conferences

The SERD elacestrant improves outcomes for patients unresponsive to endocrine therapy

Presented By

Dr Aditya Bardia, Massachusetts General Hospital, MA, USA

Trial

Phase 3, EMERALD

Conference

SABCS 2021

Type

Peer-reviewed article

31 January 2022 17:29

Early switch to fulvestrant plus palbociclib beneficial for patients with ESR1 mutation

Presented By

Prof. François-Clément Bidard, Institut Curie, France

Trial

Phase 3, PADA-1

Conference

SABCS 2021

Type

Peer-reviewed article

31 January 2022 17:09

site created by:

© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy

HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com